TABLE 4

Summary of cut-off values, confidence interval, and correlation coefficients (R2) of calibration curves for RIS, R3, Cmax/EC50, and AUC/F2

RIS, R3, Cmax/EC50 were calculated using both Cmax-t and Cmax-u. Cut-off values for RIS, R3, Cmax/EC50 and AUC/F2 were defined as that corresponding to 20% predicted AUC change.

Hepatocyte 
Lot No.ParametersRISR3Cmax/EC50AUC/F2
Cmax-tCmax-uCmax-tCmax-uCmax-tCmax-u
mRNA Data
Lot 295Cut-off valuea0.740.0170.570.980.940.00886.2
95% CI0.540.0130.200.0290.0790.000847.0
R20.910.970.910.980.970.9950.94
Lot 312Cut-off valuea1.320.0190.440.980.230.005612
95% CI0.280.00930.0620.0370.460.00283.4
R20.970.990.970.980.840.990.97
Lot 318Cut-off valuea0.620.0110.620.990.330.00382.3
95% CI0.350.0110.180.0140.210.00212.6
R20.960.960.970.970.970.970.95
Activity Data
Lot 295Cut-off valuea0.600.0170.630.980.620.00698.8
95% CI0.630.0110.280.0260.430.00345.4
R20.870.970.870.980.880.980.98
Lot 312Cut-off valuea0.840.0130.560.990.580.0054.4
95% CI0.370.00690.130.0230.150.00252.7
R20.930.980.930.980.970.990.97
Lot 318Cut-off valuea0.570.00780.650.9950.530.00521.0
95% CI0.180.00390.0840.0200.340.00253.2
R20.970.990.970.980.960.990.78
  • CI, confidence interval.

  • a Values were either over- or underpredicted on the basis of the 0.9 cut-off value provided in the 2012 FDA draft guidance.